$0.03
−43.10%Price chart
Aug 7Aug 12Aug 19Aug 25Aug 31Sep 8Sep 14Sep 18
Key dataSep 18, 2026
Open$0.04
From 52W high−64.75%
Volume38505.00
Market cap$589959.46
P/E (TTM)—
P/S (TTM)2.9x
Div yield—
Key dataSep 18, 2026
Open
$0.04
From 52W high
−64.75%
Volume
38505.00
Market cap
$589959.46
ValuationView details →
P/E (Fwd)
—
EV/EBITDA
0.8x
P/E (TTM)
—
RSI (14)
55.8
MomentumView details →
1D Return
−43.10%
YTD Return
+35.99%
SummaryUpdated Jun 1, 2026
Envoy Medical, Inc. (NASDAQ:COCH) is a hearing health company founded in 1995 and headquartered in White Bear Lake, Minnesota. Originally established as St. Croix Medical, Inc., the company changed its name to Envoy Medical Corporation in December 2004 before becoming Envoy Medical, Inc. The company went public in April 2021 and develops medical technologies designed to address various forms of hearing loss across the hearing loss spectrum.
Similar companies
Latest newsMore news →
Envoy Medical, Inc. appointed Robert Potashnick as Chief Accounting Officer and Vice President of Finance, effective August 24, 2026.25d agoEnvoy Medical reported financial results for the second quarter ended June 30, 2026, on August 10, 2026.41d agoEnvoy Medical announced that all 56 patients in its pivotal clinical trial for the Acclaim cochlear implant have passed the three-month visit milestone.61d ago